155 related articles for article (PubMed ID: 35138583)
1. Evaluation of a predictive model of end-stage kidney disease in a French-based cohort.
Ingwiller M; Krummel T; Dimitrov Y; Muller C; Ott J; Chantrel F; Klein A; Hannedouche T;
Int Urol Nephrol; 2022 Sep; 54(9):2335-2342. PubMed ID: 35138583
[TBL] [Abstract][Full Text] [Related]
2. Prediction of End-Stage Kidney Disease Using Estimated Glomerular Filtration Rate With and Without Race : A Prospective Cohort Study.
Bundy JD; Mills KT; Anderson AH; Yang W; Chen J; He J;
Ann Intern Med; 2022 Mar; 175(3):305-313. PubMed ID: 35007146
[TBL] [Abstract][Full Text] [Related]
3. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.
Wang Y; Nguyen FNHL; Allen JC; Lew JQL; Tan NC; Jafar TH
BMC Nephrol; 2019 Dec; 20(1):451. PubMed ID: 31801468
[TBL] [Abstract][Full Text] [Related]
4. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort.
Kwek JL; Pang HQJ; Li H; Lim WWL; Choo JCJ; Choong HL; Foo MWY; Chan CM
Singapore Med J; 2022 Jun; 63(6):313-318. PubMed ID: 36043308
[TBL] [Abstract][Full Text] [Related]
5. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
[TBL] [Abstract][Full Text] [Related]
6. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
7. Validation of the kidney failure risk equation in a Portuguese cohort.
da Silva BM; Charreu J; Duarte I; Outerelo C; Gameiro J
Nefrologia (Engl Ed); 2023; 43(4):467-473. PubMed ID: 36529658
[TBL] [Abstract][Full Text] [Related]
8. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
Ali I; Donne RL; Kalra PA
BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Kidney Failure Risk Equation in Manitoba.
Whitlock RH; Chartier M; Komenda P; Hingwala J; Rigatto C; Walld R; Dart A; Tangri N
Can J Kidney Health Dis; 2017; 4():2054358117705372. PubMed ID: 28491341
[TBL] [Abstract][Full Text] [Related]
10. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
11. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
[TBL] [Abstract][Full Text] [Related]
12. CKD stage-specific utility of two equations for predicting 1-year risk of ESKD.
Zheng S; Parikh RV; Tan TC; Pravoverov L; Patel JK; Horiuchi KM; Go AS
PLoS One; 2023; 18(11):e0293293. PubMed ID: 37910454
[TBL] [Abstract][Full Text] [Related]
13. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes.
Duan S; Geng L; Lu F; Chen C; Jiang L; Chen S; Zhang C; Huang Z; Zeng M; Sun B; Zhang B; Mao H; Xing C; Zhang Y; Yuan Y
Diabetes Metab Syndr; 2024 Feb; 18(2):102963. PubMed ID: 38373384
[TBL] [Abstract][Full Text] [Related]
14. A prediction model on incident ESKD among individuals with T2D and CKD.
Lin Y; Shao H; Fonseca V; Anderson AH; Batuman V; Shi L
J Diabetes Complications; 2023 Apr; 37(4):108450. PubMed ID: 36871314
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
[TBL] [Abstract][Full Text] [Related]
16. Validation of the kidney failure risk equation in European CKD patients.
Peeters MJ; van Zuilen AD; van den Brand JA; Bots ML; Blankestijn PJ; Wetzels JF;
Nephrol Dial Transplant; 2013 Jul; 28(7):1773-9. PubMed ID: 23645476
[TBL] [Abstract][Full Text] [Related]
17. Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort Study.
Zhang X; Luo F; Chen R; Shen J; Liu X; Shi Y; Yang Q; Huang T; Li H; Hu Y; Wan Q; Chen C; Jia N; Cao Y; Li Y; Zhao H; Su L; Gao P; Xu X; Nie S; Hou FF
Am J Kidney Dis; 2023 Apr; 81(4):416-424.e1. PubMed ID: 36252881
[TBL] [Abstract][Full Text] [Related]
18. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
19. Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses.
De Nicola L; Serra R; Provenzano M; Minutolo R; Michael A; Ielapi N; Federico S; Carrano R; Bellizzi V; Garofalo C; Iodice C; Borrelli S; Grandaliano G; Stallone G; Gesualdo L; Chiodini P; Andreucci M
Nephrol Dial Transplant; 2023 Feb; 38(2):507-516. PubMed ID: 35278077
[TBL] [Abstract][Full Text] [Related]
20. Predicting kidney failure from longitudinal kidney function trajectory: A comparison of models.
van den Brand JAJG; Dijkstra TMH; Wetzels J; Stengel B; Metzger M; Blankestijn PJ; Lambers Heerspink HJ; Gansevoort RT
PLoS One; 2019; 14(5):e0216559. PubMed ID: 31071186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
